Total Payments
$1,096
2024 Payments
$43.89
Companies
13
Transactions
18
Medicare Patients
1,890
Medicare Billing
$307,735
Payment Breakdown by Category
Food & Beverage$965.68 (88.1%)
Education$129.93 (11.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $965.68 | 15 | 88.1% |
| Education | $129.93 | 3 | 11.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $202.41 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $144.00 | 2 | $0 (2023) |
| Jazz Pharmaceuticals Inc. | $125.71 | 1 | $0 (2023) |
| Seagen Inc. | $124.99 | 1 | $0 (2023) |
| GENZYME CORPORATION | $120.22 | 1 | $0 (2023) |
| EMD Serono, Inc. | $99.99 | 1 | $0 (2023) |
| Incyte Corporation | $99.00 | 1 | $0 (2023) |
| Novocure Inc. | $56.63 | 2 | $0 (2017) |
| Pharmacyclics LLC, An AbbVie Company | $37.02 | 2 | $0 (2023) |
| Exelixis Inc. | $35.00 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43.89 | 2 | ABBVIE INC. ($22.62) |
| 2023 | $950.43 | 11 | Janssen Biotech, Inc. ($202.41) |
| 2022 | $13.73 | 1 | Exelixis Inc. ($13.73) |
| 2021 | $30.93 | 2 | AstraZeneca Pharmaceuticals LP ($19.01) |
| 2017 | $56.63 | 2 | Novocure Inc. ($56.63) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/11/2024 | ABBVIE INC. | EPKINLY (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: ONCOLOGY | ||||||
| 05/30/2024 | Exelixis Inc. | CABOMETYX (Drug) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC) | ||||||
| 11/15/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $99.99 | General |
| Category: Oncology | ||||||
| 11/09/2023 | Jazz Pharmaceuticals Inc. | ZEPZELCA (Drug) | Food and Beverage | In-kind items and services | $125.71 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 10/25/2023 | Janssen Biotech, Inc. | DARZALEX (Biological), TECVAYLI, CARVYKTI | Food and Beverage | In-kind items and services | $92.50 | General |
| Category: Oncology | ||||||
| 08/30/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $109.91 | General |
| Category: Oncology | ||||||
| 08/09/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $120.22 | General |
| Category: Oncology | ||||||
| 08/07/2023 | Foundation Medicine, Inc. | FOUNDATIONONE CDX (Device) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: Oncology | ||||||
| 07/19/2023 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 06/15/2023 | Seagen Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Oncology | ||||||
| 04/20/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.00 | General |
| 02/14/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2023 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 04/14/2022 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Oncology | ||||||
| 10/11/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Education | In-kind items and services | $19.01 | General |
| Category: Oncology | ||||||
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 11/29/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $42.27 | General |
| Category: Oncology | ||||||
| 04/20/2017 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $14.36 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 364 | 736 | $173,743 | $62,843 |
| 2022 | 6 | 384 | 700 | $168,272 | $63,376 |
| 2021 | 8 | 491 | 1,040 | $278,939 | $89,338 |
| 2020 | 9 | 651 | 1,293 | $348,502 | $92,178 |
Total Patients
1,890
Total Services
3,769
Medicare Billing
$307,735
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 82 | 285 | $77,657 | $30,288 | 39.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 202 | 370 | $71,569 | $25,451 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $8,531 | $2,378 | 27.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 21 | 22 | $7,382 | $2,022 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,598 | $1,963 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,005 | $740.59 | 36.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 81 | 254 | $69,210 | $28,527 | 41.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 186 | 325 | $62,865 | $23,381 | 37.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 42 | 46 | $15,435 | $4,834 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 34 | 34 | $10,743 | $3,263 | 30.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $7,011 | $2,318 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 24 | $3,008 | $1,053 | 35.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 109 | 365 | $113,676 | $39,039 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 246 | 517 | $119,898 | $36,007 | 30.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 32 | 32 | $14,188 | $4,488 | 31.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 38 | $8,813 | $2,447 | 27.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $5,626 | $1,973 | 35.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 15 | 15 | $5,264 | $1,550 | 29.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $4,422 | $1,541 | 34.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 16 | 27 | $4,174 | $1,471 | 35.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 18 | 18 | $2,878 | $822.88 | 28.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 265 | 632 | $146,624 | $36,766 | 25.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 140 | 392 | $121,520 | $31,702 | 26.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 76 | 76 | $33,440 | $9,553 | 28.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 20 | 21 | $9,051 | $3,282 | 36.3% |
About Dr. Avinash Pasam, MD
Dr. Avinash Pasam, MD is a Medical Oncology healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/04/2010. The National Provider Identifier (NPI) number assigned to this provider is 1750609582.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Avinash Pasam, MD has received a total of $1,096 in payments from pharmaceutical and medical device companies, with $43.89 received in 2024. These payments were reported across 18 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($965.68).
As a Medicare-enrolled provider, Pasam has provided services to 1,890 Medicare beneficiaries, totaling 3,769 services with total Medicare billing of $307,735. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical Oncology
- Other Specialties Hematology
- Location Fayetteville, NC
- Active Since 05/04/2010
- Last Updated 06/27/2024
- Taxonomy Code 207RX0202X
- Entity Type Individual
- NPI Number 1750609582
Products in Payments
- LYNPARZA (Drug) $144.00
- ZEPZELCA (Drug) $125.71
- ADCETRIS (Biological) $124.99
- SARCLISA (Biological) $120.22
- ERLEADA (Drug) $109.91
- BAVENCIO (Drug) $99.99
- DARZALEX (Biological) $92.50
- Optune (Device) $56.63
- IMBRUVICA (Drug) $37.02
- EPKINLY (Drug) $22.62
- CABOMETYX (Drug) $21.27
- FOUNDATIONONE CDX (Device) $16.10
- Cabometyx (Drug) $13.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Oncology Doctors in Fayetteville
Anusha Madadi, Md, MD
Medical Oncology — Payments: $49,054
Medical Oncology $49,054
Kenneth Manning, M.d, M.D
Medical Oncology — Payments: $10,407
Medical Oncology $10,407
Dr. Sydney Welt, Md, MD
Medical Oncology — Payments: $5,487
Medical Oncology $5,487
Dr. Gayathri Bhagwath, M.d, M.D
Medical Oncology — Payments: $2,477
Medical Oncology $2,477